Target intelligence / Profile preview

Ribosomal protein L29 pseudogene 35 (RPL29P35)

Target
RPL29P35
Molecular classification
Other
01

Overview

Ribosomal protein L29 pseudogene 35 (RPL29P35) is classified as a processed pseudogene in the human genome and is not believed to encode a functional protein. Pseudogenes are segments of DNA that are similar to known genes but typically lack the ability to produce a functional protein product and do not participate in normal biological pathways or processes. RPL29P35 is related to the functional ribosomal protein L29 gene (RPL29), which encodes a component of the 60S large ribosomal subunit; however, RPL29P35 itself does not contribute to ribosome structure or function, and there is no evidence implicating it as a therapeutic target, biomarker, or disease-associated gene. There is nothing to suggest that RPL29P35 is a therapeutic target, enzyme, transporter, receptor, or otherwise involved in drug interaction or clinical intervention. Its status as a pseudogene means it is not functionally equivalent to the ribosomal protein L29 (RPL29), which *is* a ribosomal subunit and has biological functions but is unrelated in terms of therapeutic targeting. This entry is marked as "is_incorrect: true" because querying RPL29P35 as a functional target is not appropriate, given its known status as a pseudogene lacking protein-coding ability or therapeutic implication.

Other names
RPL29P35
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on Ribosomal protein L29 pseudogene 35 (RPL29P35).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L29 pseudogene 35 (RPL29P35).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call